236 related articles for article (PubMed ID: 18962898)
1. Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation.
Sjöberg AP; Manderson GA; Mörgelin M; Day AJ; Heinegård D; Blom AM
Mol Immunol; 2009 Feb; 46(5):830-9. PubMed ID: 18962898
[TBL] [Abstract][Full Text] [Related]
2. Complement inhibitor C4b-binding protein interacts directly with small glycoproteins of the extracellular matrix.
Happonen KE; Sjöberg AP; Mörgelin M; Heinegård D; Blom AM
J Immunol; 2009 Feb; 182(3):1518-25. PubMed ID: 19155499
[TBL] [Abstract][Full Text] [Related]
3. The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q.
Sjöberg A; Onnerfjord P; Mörgelin M; Heinegård D; Blom AM
J Biol Chem; 2005 Sep; 280(37):32301-8. PubMed ID: 16046396
[TBL] [Abstract][Full Text] [Related]
4. Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site.
Monfort J; Tardif G; Reboul P; Mineau F; Roughley P; Pelletier JP; Martel-Pelletier J
Arthritis Res Ther; 2006; 8(1):R26. PubMed ID: 16507124
[TBL] [Abstract][Full Text] [Related]
5. Colocalization of the collagen-binding proteoglycans decorin, biglycan, fibromodulin and lumican with different cells in human gingiva.
Alimohamad H; Habijanac T; Larjava H; Häkkinen L
J Periodontal Res; 2005 Feb; 40(1):73-86. PubMed ID: 15613083
[TBL] [Abstract][Full Text] [Related]
6. NC4 Domain of cartilage-specific collagen IX inhibits complement directly due to attenuation of membrane attack formation and indirectly through binding and enhancing activity of complement inhibitors C4B-binding protein and factor H.
Kalchishkova N; Fürst CM; Heinegård D; Blom AM
J Biol Chem; 2011 Aug; 286(32):27915-26. PubMed ID: 21659506
[TBL] [Abstract][Full Text] [Related]
7. Interactions of the extracellular matrix proteoglycans decorin and biglycan with C1q and collectins.
Groeneveld TW; Oroszlán M; Owens RT; Faber-Krol MC; Bakker AC; Arlaud GJ; McQuillan DJ; Kishore U; Daha MR; Roos A
J Immunol; 2005 Oct; 175(7):4715-23. PubMed ID: 16177119
[TBL] [Abstract][Full Text] [Related]
8. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
Sjöberg AP; Nyström S; Hammarström P; Blom AM
Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
[TBL] [Abstract][Full Text] [Related]
9. Super-motifs and evolution of tandem leucine-rich repeats within the small proteoglycans--biglycan, decorin, lumican, fibromodulin, PRELP, keratocan, osteoadherin, epiphycan, and osteoglycin.
Matsushima N; Ohyanagi T; Tanaka T; Kretsinger RH
Proteins; 2000 Feb; 38(2):210-25. PubMed ID: 10656267
[TBL] [Abstract][Full Text] [Related]
10. Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans.
McEwan PA; Scott PG; Bishop PN; Bella J
J Struct Biol; 2006 Aug; 155(2):294-305. PubMed ID: 16884925
[TBL] [Abstract][Full Text] [Related]
11. Small leucine-rich proteoglycans in kidney disease.
Schaefer L
J Am Soc Nephrol; 2011 Jul; 22(7):1200-7. PubMed ID: 21719787
[TBL] [Abstract][Full Text] [Related]
12. Class I and Class II small leucine-rich proteoglycans in human cutaneous pacinian corpuscles.
García-Piqueras J; García-Mesa Y; Feito J; García B; Quiros LM; Martín-Biedma B; Cobo T; Vega JA; García-Suárez O
Ann Anat; 2019 Jul; 224():62-72. PubMed ID: 31005573
[TBL] [Abstract][Full Text] [Related]
13. Small Leucine-Rich Proteoglycans (SLRPs) in the Retina.
Low SWY; Connor TB; Kassem IS; Costakos DM; Chaurasia SS
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298915
[TBL] [Abstract][Full Text] [Related]
14. Interaction of
Colineau L; Laabei M; Liu G; Ermert D; Lambris JD; Riesbeck K; Blom AM
Matrix Biol Plus; 2020 May; 6-7():100020. PubMed ID: 33543018
[No Abstract] [Full Text] [Related]
15. Structural and functional analysis of two small leucine-rich repeat proteoglycans, fibromodulin and chondroadherin.
Paracuellos P; Kalamajski S; Bonna A; Bihan D; Farndale RW; Hohenester E
Matrix Biol; 2017 Nov; 63():106-116. PubMed ID: 28215822
[TBL] [Abstract][Full Text] [Related]
16. SLRP interaction can protect collagen fibrils from cleavage by collagenases.
Geng Y; McQuillan D; Roughley PJ
Matrix Biol; 2006 Oct; 25(8):484-91. PubMed ID: 16979885
[TBL] [Abstract][Full Text] [Related]
17. Molecular cues for immune cells from small leucine-rich repeat proteoglycans in their extracellular matrix-associated and free forms.
Maiti G; Ashworth S; Choi T; Chakravarti S
Matrix Biol; 2023 Nov; 123():48-58. PubMed ID: 37793508
[TBL] [Abstract][Full Text] [Related]
18. Differential MMP-14 targeting by biglycan, decorin, fibromodulin, and lumican unraveled by in silico approach.
Rivet R; Rao RM; Nizet P; Belloy N; Huber L; Dauchez M; Ramont L; Baud S; Brézillon S
Am J Physiol Cell Physiol; 2023 Feb; 324(2):C353-C365. PubMed ID: 36534501
[TBL] [Abstract][Full Text] [Related]
19. Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway.
Tan LA; Yang AC; Kishore U; Sim RB
Protein Cell; 2011 Apr; 2(4):320-32. PubMed ID: 21574022
[TBL] [Abstract][Full Text] [Related]
20. Small leucine rich repeat proteoglycans (SLRPs) in the human sclera: identification of abundant levels of PRELP.
Johnson JM; Young TL; Rada JA
Mol Vis; 2006 Sep; 12():1057-66. PubMed ID: 17093390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
